Olema Pharmaceuticals, Inc. OLMA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s accounts payable?
- Olema Pharmaceuticals, Inc. (OLMA) reported accounts payable of $3.72M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Olema Pharmaceuticals, Inc.'s accounts payable increased by 2362.9% year-over-year, from $151K to $3.72M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s accounts payable has grown at a 86.9% compound annual growth rate (CAGR), from $1.13M to $13.81M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.